FWIA
BMRN icon

Fort Washington Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Fort Washington Investment Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.9M Buy
715,646
+1,110
+0.2% +$60.8K 0.21% 125
2026
Q1 		$40.4M Buy
714,536
+557
+0.1% +$32.5K 0.22% 110
2025
Q4 		$42.4M Buy
713,979
+23
+0% +$1.25K 0.23% 107
2025
Q3 		$38.7M Buy
713,956
+110
+0% +$6.29K 0.21% 108
2025
Q2 		$39.2M Sell
713,846
-1,203
-0.2% -$70.8K 0.23% 106
2025
Q1 		$50.5M Sell
715,049
-451
-0.1% -$30.3K 0.31% 82
2024
Q4 		$47M Sell
715,500
-12,170
-2% -$815K 0.28% 88
2024
Q3 		$51.1M Sell
727,670
-250,968
-26% -$21M 0.31% 81
2024
Q2 		$80.6M Sell
978,638
-188,617
-16% -$15.7M 0.53% 48
2024
Q1 		$102M Buy
1,167,255
+1,666
+0.1% +$149K 0.66% 39
2023
Q4 		$112M Sell
1,165,589
-142,656
-11% -$12.6M 0.78% 34
2023
Q3 		$116M Buy
1,308,245
+126,680
+11% +$11.3M 0.87% 31
2023
Q2 		$102M Buy
1,181,565
+36,754
+3% +$3.46M 0.74% 34
2023
Q1 		$111M Sell
1,144,811
-1,244
-0.1% -$129K 0.84% 30
2022
Q4 		$119M Buy
1,146,055
+459
+0% +$43.1K 0.92% 28
2022
Q3 		$97.1M Sell
1,145,596
-90,463
-7% -$8.05M 0.81% 30
2022
Q2 		$102M Buy
1,236,059
+1,050
+0.1% +$83.6K 0.79% 31
2022
Q1 		$95.2M Buy
1,235,009
+91,378
+8% +$7.65M 0.6% 39
2021
Q4 		$101M Buy
1,143,631
+551,729
+93% +$45.5M 0.61% 48
2021
Q3 		$45.7M Buy
+591,902
New +$46.7M 0.29% 89
2019
Q1 		– Sell
-4,590
Closed -$391K – 511
2018
Q4 		$391K Hold
4,590
– – ﹤0.01% 418
2018
Q3 		$445K Hold
4,590
– – ﹤0.01% 439
2018
Q2 		$432K Sell
4,590
-200
-4% -$17.5K ﹤0.01% 450
2018
Q1 		$388K Sell
4,790
-1,200
-20% -$103K ﹤0.01% 471
2017
Q4 		$534K Sell
5,990
-160
-3% -$13.9K 0.01% 468
2017
Q3 		$572K Sell
6,150
-1,600
-21% -$141K 0.01% 381
2017
Q2 		$704K Sell
7,750
-1,900
-20% -$173K 0.01% 354
2017
Q1 		$847K Hold
9,650
– – 0.01% 342
2016
Q4 		$799K Hold
9,650
– – 0.01% 336
2016
Q3 		$893K Buy
9,650
+300
+3% +$28.3K 0.02% 283
2016
Q2 		$727K Buy
9,350
+225
+2% +$19.1K 0.01% 316
2016
Q1 		$753K Buy
+9,125
New +$742K 0.01% 312
2015
Q4 		– Sell
-10,290
Closed -$1.08M – 389
2015
Q3 		$1.08M Sell
10,290
-1,370
-12% -$183K 0.02% 273
2015
Q2 		$1.59M Sell
11,660
-100
-0.9% -$12.4K 0.03% 222
2015
Q1 		$1.47M Sell
11,760
-125
-1% -$13.2K 0.03% 228
2014
Q4 		$1.07M Buy
11,885
+600
+5% +$49.9K 0.02% 267
2014
Q3 		$814K Buy
11,285
+750
+7% +$49.3K 0.02% 290
2014
Q2 		$655K Buy
10,535
+2,300
+28% +$139K 0.01% 316
2014
Q1 		$562K Sell
8,235
-80,395
-91% -$5.92M 0.01% 314
2013
Q4 		$6.24M Sell
88,630
-7,052
-7% -$479K 0.14% 114
2013
Q3 		$6.91M Sell
95,682
-113,784
-54% -$7.56M 0.17% 101
2013
Q2 		$11.7M Buy
+209,466
New +$13.1M 0.27% 83

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Fort Washington Investment Advisors's BMRN Position: Q2 2026 in Review

Fort Washington Investment Advisors increased its BioMarin Pharmaceuticals (BMRN) stake by 0.16% in Q2 2026, buying an estimated $60.8K and bringing the position to 715,646 shares worth $40.9M. The position accounts for 0.21% of the portfolio, ranked #125.

Fort Washington Investment Advisors first reported a position in BMRN in Q2 2013 and has held it in 42 quarters since. The position peaked at $119M in Q4 2022. 148 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Fort Washington Investment Advisors held 715,646 shares of BioMarin Pharmaceuticals worth $40.9M as of Q2 2026.
  • Fort Washington Investment Advisors bought 1,110 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $60.8K.
  • BioMarin Pharmaceuticals made up 0.21% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #125 holding.
  • Fort Washington Investment Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
  • Fort Washington Investment Advisors's BioMarin Pharmaceuticals position peaked at $119M in Q4 2022.
  • 148 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.